Derivatives of phosphonoacyl prolines and their pharmaceutical use
申请人:E.R. Squibb & Sons, Inc.
公开号:EP0000833A1
公开(公告)日:1979-02-21
New phosphonoacyl prolines and related compounds have the general formula
wherein R1 and R2 each is hydrogen, lower alkyl, lower alkenyl, unsubstituted or substituted phenyl-lower alkyl, or a metal ion; R3 is hydrogen or lower alkyl; R4 is hydrogen, lower alkyl, plenyl-lower alkyl or a metal ion; and n is 0 or 1.
I These compounds may be used as hypotensive agents in the treament of mammals.
New phosphonoacyl prolines and related compounds have the general formula ##STR1## wherein R.sub.1 and R.sub.2 each is hydrogen, lower alkyl, lower alkenyl, unsustituted or substituted phenyl-lower alkyl, or a metal ion; R.sub.3 is hydrogen or lower alkyl; R.sub.4 is hydrogen, lower alkyl, phenyl-lower alkyl or a metal ion; and N is 0 or 1. These compounds are useful as hypotensive agents.